Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
AARD
AARD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest AARD ETF News Today | Earnings, Events & Price Alerts
AARD News
Aardvark Pauses Phase 3 Trial, Stock Plunges 61%
45m ago
Benzinga
Aardvark Therapeutics Faces Securities Fraud Investigation
16h ago
Globenewswire
Wall Street Analysts Adjust Ratings on Key Stocks
1d ago
Benzinga
U.S. Stocks Mixed Amid Iran-U.S. Conflict; Energy Shares Rise
1d ago
Benzinga
U.S. Stocks Open Lower; Energy Shares Rise Amid Mixed Economic Data
1d ago
Benzinga
Aardvark Pauses HERO Phase 3 Trial Amid Safety Concerns
1d ago
stocktwits
Wall Street Analysts Adjust Ratings on Key Stocks
2d ago
Benzinga
Wall Street Analysts Adjust Ratings
2d ago
Benzinga
Aardvark Pauses HERO Trial, Shares Plummet
2d ago
Benzinga
U.S. Stock Futures Plunge Amid Iran Conflict Escalation
2d ago
Benzinga
AMTD Digital Inc Reports 565.7% Revenue Growth in FY25
2d ago
Benzinga
Aardvark Therapeutics Faces Investigation After Trial Pause
3d ago
Businesswire
Aardvark Therapeutics Pauses HERO Trial Amid Safety Concerns
4d ago
NASDAQ.COM
Aardvark Pauses PWS Trial, Shares Plunge 53%
4d ago
stocktwits
AARDVARK THERAPEUTICS INC - TEMPORARY HALT CAUSED BY CARDIAC FINDINGS AT ELEVATED DOSES
4d ago
moomoo
AARDVARK THERAPEUTICS: TEMPORARY SUSPENSION OF HERO & OPEN-LABEL EXTENSION TRIALS DUE TO REVERSIBLE CARDIAC FINDINGS AT EXCEEDING TARGET DOSES
4d ago
moomoo
Show More News
